Covista Inc.·4

Mar 12, 9:01 AM ET

MALAFRONTE MICHAEL W 4

4 · Covista Inc. · Filed Mar 12, 2026

Research Summary

AI-generated summary of this filing

Updated

Covista (CVSA) Lead Director Michael Malafronte Buys Stock

What Happened
Michael W. Malafronte, Covista’s Lead Independent Director, made open-market purchases of company stock on March 10–11, 2026. He acquired 11,841 shares at a weighted average price of $100.86 ($1,194,339), 15,305 shares at $100.86 ($1,543,734) on March 10, and 8,890 shares at a weighted average price of $100.94 ($897,341) on March 11 — a total of 36,036 shares for approximately $3,635,414. These transactions are purchases (reporting code P), which are often viewed as a bullish signal but do not by themselves indicate the insider’s motive.

Key Details

  • Transaction dates: March 10, 2026 (two buys) and March 11, 2026 (one buy). Form filed March 12, 2026.
  • Reported prices (weighted averages): $100.86 (March 10 trades) and $100.94 (March 11 trade). Total consideration ≈ $3.64M.
  • Price ranges by footnote: March 10 trades executed in multiple trades at $99.51–$102.73 (weighted avg reported). March 11 trades executed in multiple trades at $100.58–$101.00 (weighted avg reported). The filer offers to provide details of individual trade prices on request.
  • Ownership after transaction: not specified in the provided filing excerpt.
  • Footnote: Reported securities are held by an irrevocable trust for which Malafronte serves as trustee.
  • Timeliness: Filing date (Mar 12) follows the reported trade dates (Mar 10–11); the filing does not indicate a late report.

Context

  • These were open-market purchases (not option exercises, awards, or gifts). Purchases by directors can be of interest to investors as a direct cash commitment to the company, but they do not guarantee future performance.
  • The shares are reported as held via an irrevocable trust (the director is trustee), which can affect how ownership is reported and managed.

Insider Transaction Report

Form 4
Period: 2026-03-10
Transactions
  • Purchase

    Common Stock

    [F1]
    2026-03-10$100.86/sh+11,841$1,194,339113,205 total
  • Purchase

    Common Stock

    [F2][F1]
    2026-03-10$100.86/sh+15,305$1,543,73416,505 total(indirect: By Trust)
  • Purchase

    Common Stock

    [F2][F3]
    2026-03-11$100.94/sh+8,890$897,34125,395 total(indirect: By Trust)
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $99.51 to $102.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]The reported securities are held by an irrevocable trust of which the reporting person serves as a trustee.
  • [F3]This transaction was executed in multiple trades at prices ranging from $100.58 to $101.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Signature
/s/ Lawrence C. Bachman, attorney-in-fact for Mr. Malafronte|2026-03-12

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT